Title | Type | SJR | H index | Total Docs. (2020) | Total Docs. (3years) | Total Refs. (2020) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2020) | %Female (2020) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Journal for ImmunoTherapy of Cancer | journal | 5.060 Q1 | 117 | 508 | 582 | 19284 | 7039 | 571 | 11.60 | 37.96 | 41.40 | |
2 | Protein and Cell | journal | 2.973 Q1 | 94 | 95 | 308 | 3915 | 1901 | 194 | 6.45 | 41.21 | 41.31 | |
3 | npj Vaccines | journal | 2.691 Q1 | 47 | 105 | 134 | 5348 | 869 | 133 | 6.16 | 50.93 | 44.39 | |
4 | Emerging Microbes and Infections | journal | 2.475 Q1 | 94 | 302 | 489 | 10395 | 2907 | 413 | 6.02 | 34.42 | 41.11 | |
5 | International Journal of Neuropsychopharmacology | journal | 1.897 Q1 | 125 | 51 | 308 | 3211 | 1584 | 299 | 4.77 | 62.96 | 37.23 | |
6 | Expert Review of Vaccines | journal | 1.864 Q1 | 105 | 94 | 314 | 8262 | 1569 | 289 | 4.67 | 87.89 | 42.93 | |
7 | PharmacoEconomics | journal | 1.809 Q1 | 118 | 112 | 359 | 4864 | 1371 | 314 | 3.77 | 43.43 | 42.63 | |
8 | npj Systems Biology and Applications | journal | 1.752 Q1 | 35 | 33 | 114 | 1694 | 498 | 114 | 4.37 | 51.33 | 27.05 | |
9 | Particle and Fibre Toxicology | journal | 1.748 Q1 | 119 | 61 | 145 | 4821 | 1293 | 143 | 8.71 | 79.03 | 45.32 | |
10 | Therapeutic Advances in Neurological Disorders | journal | 1.684 Q1 | 68 | 70 | 188 | 3450 | 1063 | 174 | 5.77 | 49.29 | 41.01 | |
11 | Journal of Nanobiotechnology | journal | 1.629 Q1 | 109 | 167 | 315 | 9606 | 3159 | 313 | 10.28 | 57.52 | 42.46 | |
12 | Human Genomics | journal | 1.414 Q1 | 68 | 44 | 150 | 2229 | 607 | 148 | 3.99 | 50.66 | 43.40 | |
13 | CNS Neuroscience and Therapeutics | journal | 1.403 Q1 | 91 | 128 | 376 | 5889 | 1658 | 331 | 4.08 | 46.01 | 42.25 | |
14 | Frontiers in Pharmacology | journal | 1.384 Q1 | 154 | 2200 | 3969 | 145595 | 22327 | 3901 | 5.45 | 66.18 | 44.40 | |
15 | Biomedicine and Pharmacotherapy | journal | 1.323 Q1 | 149 | 1298 | 4730 | 81116 | 28427 | 4713 | 6.19 | 62.49 | 43.92 | |
16 | Clinical and Translational Science | journal | 1.303 Q1 | 60 | 154 | 226 | 5292 | 845 | 191 | 3.68 | 34.36 | 41.80 | |
17 | Vaccines | journal | 1.296 Q1 | 85 | 782 | 345 | 49214 | 1510 | 334 | 4.18 | 62.93 | 47.24 | |
18 | Pharmaceuticals | journal | 1.295 Q1 | 87 | 483 | 414 | 37527 | 2319 | 403 | 5.76 | 77.70 | 44.01 | |
19 | Drugs in Context | journal | 1.262 Q1 | 36 | 69 | 109 | 3474 | 591 | 109 | 5.91 | 50.35 | 40.97 | |
20 | Drug Delivery | journal | 1.189 Q1 | 95 | 154 | 500 | 8061 | 3251 | 500 | 6.38 | 52.34 | 44.57 | |
21 | EPMA Journal | journal | 1.177 Q1 | 52 | 39 | 108 | 4020 | 677 | 106 | 6.61 | 103.08 | 40.79 | |
22 | International Journal of Pharmaceutics | journal | 1.153 Q1 | 258 | 1035 | 2540 | 58505 | 15446 | 2528 | 5.99 | 56.53 | 44.34 | |
23 | Cancer Chemotherapy and Pharmacology | journal | 1.112 Q1 | 122 | 193 | 747 | 6451 | 2340 | 733 | 2.95 | 33.42 | 36.83 | |
24 | F1000Research | journal | 1.099 Q1 | 105 | 670 | 2169 | 30433 | 7364 | 2106 | 3.06 | 45.42 | 38.55 | |
25 | International Journal for Parasitology: Drugs and Drug Resistance | journal | 1.071 Q1 | 47 | 52 | 162 | 3156 | 646 | 160 | 4.07 | 60.69 | 37.79 | |
26 | Pharmaceutics | journal | 1.054 Q1 | 106 | 1235 | 1028 | 86564 | 6845 | 1019 | 6.33 | 70.09 | 45.73 | |
27 | Toxins | journal | 1.047 Q1 | 116 | 786 | 1706 | 53963 | 7814 | 1671 | 4.42 | 68.66 | 45.55 | |
28 | Altex | journal | 0.975 Q2 | 64 | 67 | 157 | 2334 | 573 | 135 | 3.30 | 34.84 | 48.21 | |
29 | Pharmacology Research and Perspectives | journal | 0.975 Q1 | 43 | 131 | 251 | 6220 | 809 | 246 | 2.66 | 47.48 | 41.58 | |
30 | Chinese Medicine | journal | 0.972 Q2 | 56 | 127 | 152 | 7789 | 811 | 150 | 5.94 | 61.33 | 43.67 | |
31 | Antibiotics | journal | 0.960 Q1 | 77 | 928 | 416 | 54250 | 1995 | 408 | 4.60 | 58.46 | 47.62 | |
32 | Antiviral Chemistry and Chemotherapy | journal | 0.919 Q1 | 59 | 14 | 34 | 711 | 140 | 31 | 5.13 | 50.79 | 40.74 | |
33 | Journal of Enzyme Inhibition and Medicinal Chemistry | journal | 0.916 Q2 | 92 | 185 | 471 | 9500 | 2428 | 471 | 4.82 | 51.35 | 46.10 | |
34 | Drugs in R and D | journal | 0.873 Q2 | 54 | 37 | 131 | 1464 | 397 | 127 | 2.48 | 39.57 | 41.18 | |
35 | Marine Drugs | journal | 0.848 Q2 | 159 | 661 | 1619 | 44829 | 8703 | 1615 | 5.24 | 67.82 | 44.30 | |
36 | European Journal of Pharmaceutical Sciences | journal | 0.840 Q1 | 163 | 364 | 1335 | 19932 | 6090 | 1324 | 4.36 | 54.76 | 44.14 | |
37 | Cardiovascular Therapeutics | journal | 0.818 Q2 | 54 | 61 | 160 | 3026 | 423 | 158 | 2.58 | 49.61 | 39.29 | |
38 | EXCLI Journal | journal | 0.812 Q2 | 55 | 148 | 320 | 6772 | 1092 | 258 | 3.11 | 45.76 | 44.69 | |
39 | Journal of Cardiovascular Pharmacology and Therapeutics | journal | 0.787 Q2 | 57 | 63 | 188 | 2781 | 486 | 178 | 2.14 | 44.14 | 30.85 | |
40 | Toxics | journal | 0.783 Q2 | 51 | 127 | 172 | 8007 | 752 | 166 | 4.11 | 63.05 | 44.72 | |
41 | Molecules | journal | 0.782 Q1 | 227 | 6109 | 10322 | 377678 | 45615 | 10270 | 4.35 | 61.82 | 44.24 | |
42 | International Journal of Immunopathology and Pharmacology | journal | 0.724 Q2 | 65 | 67 | 179 | 2419 | 528 | 106 | 3.02 | 36.10 | 46.08 | |
43 | International Journal of Pharmaceutics: X | journal | 0.724 Q2 | 23 | 21 | 35 | 867 | 127 | 35 | 3.63 | 41.29 | 35.51 | |
44 | Pharmacological Reports | journal | 0.706 Q2 | 98 | 151 | 525 | 8322 | 1614 | 523 | 2.82 | 55.11 | 49.03 | |
45 | Saudi Pharmaceutical Journal | journal | 0.706 Q2 | 76 | 216 | 483 | 9993 | 2233 | 483 | 4.61 | 46.26 | 40.36 | |
46 | Pharmaceutical Biology | journal | 0.702 Q2 | 88 | 147 | 469 | 5985 | 1782 | 468 | 3.48 | 40.71 | 47.51 | |
47 | AAPS PharmSciTech | journal | 0.652 Q2 | 116 | 311 | 1021 | 14960 | 3461 | 1009 | 3.41 | 48.10 | 43.61 | |
48 | DARU, Journal of Pharmaceutical Sciences | journal | 0.645 Q2 | 58 | 70 | 121 | 3671 | 368 | 118 | 2.69 | 52.44 | 42.74 | |
49 | Journal of Pharmaceutical Policy and Practice | journal | 0.644 Q1 | 32 | 73 | 102 | 2531 | 226 | 94 | 2.44 | 34.67 | 48.23 | |
50 | PharmacoEconomics - Open | journal | 0.637 Q2 | 20 | 65 | 135 | 2345 | 263 | 120 | 1.82 | 36.08 | 42.51 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®